American Century Companies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,906
| Closed | -$20.9K | – | 2941 |
|
|
2023
Q3 | $20.9K | Buy |
+14,906
| New | +$20.9K | ﹤0.01% | 2835 |
|
|
2023
Q1 | – | Sell |
-322,030
| Closed | -$1.96M | – | 2707 |
|
|
2022
Q4 | $1.96M | Buy |
322,030
+196
| +0.1% | +$1.2K | ﹤0.01% | 1553 |
|
|
2022
Q3 | $3.85M | Buy |
321,834
+1,879
| +0.6% | +$22.5K | ﹤0.01% | 1208 |
|
|
2022
Q2 | $4.04M | Buy |
319,955
+428
| +0.1% | +$5.4K | ﹤0.01% | 1183 |
|
|
2022
Q1 | $3.6M | Buy |
319,527
+105,882
| +50% | +$1.19M | ﹤0.01% | 1212 |
|
|
2021
Q4 | $3.79M | Buy |
213,645
+39,855
| +23% | +$706K | ﹤0.01% | 1144 |
|
|
2021
Q3 | $4M | Buy |
173,790
+71
| +0% | +$1.64K | ﹤0.01% | 1090 |
|
|
2021
Q2 | $4.04M | Buy |
173,719
+248
| +0.1% | +$5.77K | ﹤0.01% | 1044 |
|
|
2021
Q1 | $5.41M | Buy |
173,471
+166,336
| +2,331% | +$5.18M | ﹤0.01% | 919 |
|
|
2020
Q4 | $284K | Buy |
+7,135
| New | +$284K | ﹤0.01% | 1751 |
|